Discovery of orally active and serine-targeting covalent inhibitors against hCES2A for ameliorating irinotecan-triggered gut toxicity
发现口服有效的、靶向丝氨酸的hCES2A共价抑制剂,以改善伊立替康引发的肠道毒性
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.08.007
Zhang, Ya; Fan, Yufan; Song, Yunqing; Zhu, Guanghao; Li, Xinjuan; Huang, Jian; Guo, Xinrui; Luan, Changhai; Kang, Dongning; Chen, Lu; Xiao, Zhangping; Guo, Zhaobin; Zeng, Hairong; Chen, Dapeng; Sang, Zhipei; Ge, Guangbo